Tomino, C.; Ilari, S.; Solfrizzi, V.; Malafoglia, V.; Zilio, G.; Russo, P.; Proietti, S.; Marcolongo, F.; Scapagnini, G.; Muscoli, C.;
et al. Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®). Pharmaceuticals 2021, 14, 305.
https://doi.org/10.3390/ph14040305
AMA Style
Tomino C, Ilari S, Solfrizzi V, Malafoglia V, Zilio G, Russo P, Proietti S, Marcolongo F, Scapagnini G, Muscoli C,
et al. Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®). Pharmaceuticals. 2021; 14(4):305.
https://doi.org/10.3390/ph14040305
Chicago/Turabian Style
Tomino, Carlo, Sara Ilari, Vincenzo Solfrizzi, Valentina Malafoglia, Guglielmo Zilio, Patrizia Russo, Stefania Proietti, Federica Marcolongo, Giovanni Scapagnini, Carolina Muscoli,
and et al. 2021. "Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®)" Pharmaceuticals 14, no. 4: 305.
https://doi.org/10.3390/ph14040305
APA Style
Tomino, C., Ilari, S., Solfrizzi, V., Malafoglia, V., Zilio, G., Russo, P., Proietti, S., Marcolongo, F., Scapagnini, G., Muscoli, C., & Rossini, P. M.
(2021). Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®). Pharmaceuticals, 14(4), 305.
https://doi.org/10.3390/ph14040305